First international external quality assessment for hepatitis delta virus RNA quantification in plasma
Frédéric Le Gal(Sorbonne Université), Emmanuel Gordien(Université Paris Cité), Ségolène Brichler(Centre National de la Recherche Scientifique), Sylvie Chevret(Saint Louis University Hospital), Roland Sahli(University of Lausanne)
Cited by 122
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|994
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia
|Blood|2013|357
Gemtuzumab ozogamicin for <i>de novo</i> acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
|Haematologica|2018|349
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study
|Intensive Care Medicine|2017|309